Management of Persistently Elevated Liver Enzymes

Initial Assessment and Pattern Recognition

The American College of Gastroenterology recommends determining the pattern of liver enzyme elevation: hepatocellular (predominant ALT/AST elevation), cholestatic (predominant ALP/GGT elevation), or mixed pattern to guide further evaluation 2
Categorize severity of elevation: mild to moderate (<3× ULN), severe (>3× ULN), or very severe (>5× ULN) 1, 2
For ALT/AST >3× ULN, stop any potentially hepatotoxic medications and perform comprehensive evaluation 1
For severe elevations (ALT/AST >20× ULN), consider immediate hospitalization and specialist consultation 1

Review all current medications and supplements for potential hepatotoxicity 1
Obtain core laboratory panel: complete blood count with platelets, comprehensive metabolic panel, additional liver function tests: total and direct bilirubin, albumin, INR 2
Perform abdominal ultrasound to assess liver parenchyma, biliary tract, and for signs of cirrhosis or focal lesions 2
Consider additional testing based on clinical suspicion: autoimmune markers, iron studies, non-invasive fibrosis assessment (FIB-4, Fibrosure, Fibrometer, Hepascore) 2, 3

For medication-induced liver injury, immediately discontinue suspected hepatotoxic medications when ALT/AST ≥5× ULN or when ALT/AST ≥3× ULN with total bilirubin ≥2× ULN 1
For immune checkpoint inhibitor-related hepatitis, temporarily hold immune checkpoint inhibitor and administer steroids (0.5-1 mg/kg/d prednisone) if no improvement after 3-5 days 5
For non-alcoholic fatty liver disease (NAFLD), implement lifestyle modifications (weight loss, exercise) and monitor liver enzymes every 3-6 months 1, 2
For viral hepatitis, consider antiviral therapy for chronic HBV infection with elevated liver enzymes 1
For patients receiving immunosuppressive therapy, screen for HBsAg and provide antiviral prophylaxis with nucleoside analogues if positive 6

For mild elevations (<3× ULN) without clear cause, repeat testing in 2-4 weeks to establish trend 1, 2
For grade 1 elevations (ALT/AST 1-3× ULN), monitor liver enzymes every 1-2 weeks 1
For grade 2-4 elevations (ALT/AST >3× ULN), increase monitoring frequency to every 3 days until improvement 1
For persistent elevation in liver enzymes during a 12-month period or a decline in serum albumin below normal range, consider gastroenterology consultation and/or liver biopsy 3, 4

Refer patients with ALT >8× ULN or >5× baseline in those with elevated baseline 1
Refer patients with ALT >3× ULN with total bilirubin >2× ULN (meets Hy's Law criteria) 1
Refer patients with evidence of synthetic dysfunction (elevated INR, low albumin) 1
Refer patients with persistent elevation >2× ULN after 3 months despite addressing modifiable factors 2
Refer patients with imaging suggesting advanced fibrosis, cirrhosis, or focal lesions 2